Literature DB >> 3734791

Characteristics of the large neutral amino acid transport system of bovine brain microvessel endothelial cell monolayers.

K L Audus, R T Borchardt.   

Abstract

The large neutral amino acid (LNAA) transport system, or L (leucine) system, in primary cultures of bovine brain microvessel endothelial cell monolayers has been characterized. The transendothelial transport of leucine in this in vitro blood-brain barrier (BBB) model was determined to be bidirectional and time, temperature, and concentration dependent. Leucine transport was saturable, and the apparent Km and Vmax were determined to be 0.18 mM and 6.3 nmol/mg/min, respectively. Transendothelial transport of leucine was resistant to inhibition by ouabain and sodium azide. Other LNAAs, including the centrally acting drugs alpha-methyl-3,4-dihydroxyphenylalanine (alpha-methyldopa), L-3,4-dihydroxyphenylalanine (L-DOPA), alpha-methyltyrosine, and baclofen, inhibited leucine transport. The leucine carrier system was also found to be stereospecific. Sucrose, used as a diffusion marker, moved across the monolayers slowly, and its concentration was not significant for at least 30 min.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3734791     DOI: 10.1111/j.1471-4159.1986.tb04527.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

1.  Effects of selected vasoactive substances on adenylate cyclase activity in brain, isolated brain microvessels, and primary cultures of brain microvessel endothelial cells.

Authors:  A Baranczyk-Kuzma; K L Audus; F L Guillot; R T Borchardt
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

2.  The effect of protein binding on ivermectin uptake by bovine brain microvessel endothelial cells.

Authors:  K L Audus; S R Knaub; F L Guillot; J M Schaeffer
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

Review 3.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 4.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

Review 5.  The use of cultured epithelial and endothelial cells for drug transport and metabolism studies.

Authors:  K L Audus; R L Bartel; I J Hidalgo; R T Borchardt
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

6.  Carrier-mediated transport of baclofen across monolayers of bovine brain endothelial cells in primary culture.

Authors:  J B van Bree; K L Audus; R T Borchardt
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

Review 7.  Analytical and biological methods for probing the blood-brain barrier.

Authors:  Courtney D Kuhnline Sloan; Pradyot Nandi; Thomas H Linz; Jane V Aldrich; Kenneth L Audus; Susan M Lunte
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2012       Impact factor: 10.745

8.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.

Authors:  E Garcia-Garcia; S Gil; K Andrieux; D Desmaële; V Nicolas; F Taran; D Georgin; J P Andreux; F Roux; P Couvreur
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

9.  Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells.

Authors:  T Terasaki; S Takakuwa; A Saheki; S Moritani; T Shimura; S Tabata; A Tsuji
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

10.  Carrier-mediated transport of H1-antagonist at the blood-brain barrier: mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures.

Authors:  M Yamazaki; T Terasaki; K Yoshioka; O Nagata; H Kato; Y Ito; A Tsuji
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.